Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21048847rdf:typepubmed:Citationlld:pubmed
pubmed-article:21048847lifeskim:mentionsumls-concept:C0029445lld:lifeskim
pubmed-article:21048847lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:21048847lifeskim:mentionsumls-concept:C1171322lld:lifeskim
pubmed-article:21048847lifeskim:mentionsumls-concept:C0016665lld:lifeskim
pubmed-article:21048847lifeskim:mentionsumls-concept:C0585064lld:lifeskim
pubmed-article:21048847pubmed:dateCreated2010-11-4lld:pubmed
pubmed-article:21048847pubmed:abstractTextNONUNION FRACTURES AND ASEPTIC BONE NECROSIS ARE TWO PATHOLOGICAL CONDITIONS HAVING SOME IMPAIRMENT OF THE CELLULAR PART OF THE REPAIR: a reduction of MSC and of the osteoblastic activation. Both are good candidates for cell-based therapies using stem cells. We made a review of the published human trials. Only autologous bone marrow aspirate implantation was until now used. In Nonunion, a direct injection-15 to 150?ml-was made in 4 case series studies. In another, the bone marrow aspirate was concentrated before injection. The results were good. In bone necrosis, only one level 1 study was published. The results at 24 months were positive in terms of reduction of the necrosis and appearance of collapse. In 3 case series studies, a treatment with concentrated bone marrow aspirates was deemed useful with good results in 76 to 96%. These results are interesting but need confirmation by controlled studies.lld:pubmed
pubmed-article:21048847pubmed:languageenglld:pubmed
pubmed-article:21048847pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21048847pubmed:statusPubMed-not-MEDLINElld:pubmed
pubmed-article:21048847pubmed:issn1687-9678lld:pubmed
pubmed-article:21048847pubmed:authorpubmed-author:GangjiValérie...lld:pubmed
pubmed-article:21048847pubmed:authorpubmed-author:HauzeurJean-P...lld:pubmed
pubmed-article:21048847pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21048847pubmed:volume2010lld:pubmed
pubmed-article:21048847pubmed:ownerNLMlld:pubmed
pubmed-article:21048847pubmed:authorsCompleteYlld:pubmed
pubmed-article:21048847pubmed:pagination410170lld:pubmed
pubmed-article:21048847pubmed:year2010lld:pubmed
pubmed-article:21048847pubmed:articleTitlePhases 1-3 clinical trials using adult stem cells in osteonecrosis and nonunion fractures.lld:pubmed
pubmed-article:21048847pubmed:affiliationDepartment of Rheumatology, CHU Sart Tilman, B35, 4000 Liège, Belgium.lld:pubmed
pubmed-article:21048847pubmed:publicationTypeJournal Articlelld:pubmed